Volume 12, Issue 2 (May 2024)
Res Mol Med (RMM) 2024, 12(2): 65-70 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rahimlou M E, Rahimlou E, Shakibfar F, Fathi Maroufi N. Potential of SARS-CoV-2 in Cancer Development: A Hypothetical and Mechanistic View. Res Mol Med (RMM) 2024; 12 (2) :65-70
URL: http://rmm.mazums.ac.ir/article-1-582-en.html
URL: http://rmm.mazums.ac.ir/article-1-582-en.html
1- Department of Medical Laboratory Sciences, Faculty of Medicine, Marand Branch, Islamic Azad University, Marand, Iran.
2- Women’s Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
3- Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. ,n.fathi6788@gmail.com
2- Women’s Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
3- Department of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. ,
Abstract: (686 Views)
The COVID-19 pandemic caused by the SARS-CoV-2 virus can lead to long-term health effects, such as possible oncogenic properties. The evidence shows that SARS-CoV-2 may affect cellular pathways involved in cancer development, such as chronic inflammation, immune evasion, and genomic instability. This review study explores the hypothetical mechanisms by which SARS-CoV-2 contributes to oncogenesis, including persistent viral infection, dysregulation of tumor suppressor genes (e.g. p53), activation of pro-oncogenic signaling (e.g. NF-κB, JAK/STAT), and induction of long-term oxidative stress. While the evidence of the link between SARS-CoV-2 and cancer remains limited, like other oncogenic viruses, including HPV and EBV, further investigation is needed. Further epidemiological and molecular studies are needed to validate these hypotheses and assess the potential oncogenic impact of SARS-CoV-2.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
